An Improved High Yield Total Synthesis and Cytotoxicity Study of the Marine Alkaloid Neoamphimedine: An ATP-Competitive Inhibitor of Topoisomerase IIα and Potent Anticancer Agent
Open Access
- 19 September 2014
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 12 (9) , 4833-4850
Abstract
Recently, we characterized neoamphimedine (neo) as an ATP-competitive inhibitor of the ATPase domain of human Topoisomerase IIα. Thus far, neo is the only pyridoacridine with this mechanism of action. One limiting factor in the development of neo as a therapeutic agent has been access to sufficient amounts of material for biological testing. Although there are two reported syntheses of neo, both require 12 steps with low overall yields (≤6%). In this article, we report an improved total synthesis of neo achieved in 10 steps with a 25% overall yield. In addition, we report an expanded cytotoxicity study using a panel of human cancer cell lines, including: breast, colorectal, lung, and leukemia. Neo displays potent cytotoxicity (nM IC50 values) in all, with significant potency against colorectal cancer (lowest IC50 = 6 nM). We show that neo is cytotoxic not cytostatic, and that neo exerts cytotoxicity by inducing G2-M cell cycle arrest and apoptosis.Keywords
Funding Information
- U.S. Department of War (W81XWH-13-1-0344)
This publication has 60 references indexed in Scilit:
- CancerDR: Cancer Drug Resistance DatabaseScientific Reports, 2013
- The ancestral role of ATP hydrolysis in type II topoisomerases: prevention of DNA double-strand breaksNucleic Acids Research, 2011
- Topoisomerase IIα maintains genomic stability through decatenation G2 checkpoint signalingOncogene, 2010
- Deoxyamphimedine, a Pyridoacridine Alkaloid, Damages DNA via the Production of Reactive Oxygen SpeciesMarine Drugs, 2009
- DNA topoisomerase II and its growing repertoire of biological functionsNature Reviews Cancer, 2009
- Targeting DNA topoisomerase II in cancer chemotherapyNature Reviews Cancer, 2009
- Discovery of Inhibitors of Aberrant Gene Transcription from Libraries of DNA Binding Molecules: Inhibition of LEF-1-Mediated Gene Transcription and Oncogenic TransformationJournal of the American Chemical Society, 2009
- The Total Synthesis of NeoamphimedineThe Journal of Organic Chemistry, 2007
- Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignanciesProceedings of the National Academy of Sciences, 2007
- C-Terminal regions of topoisomerase II and II determine isoform-specific functioning of the enzymes in vivoNucleic Acids Research, 2007